Transplant glomerulopathy: The interaction of HLA antibodies and endothelium

Journal of Immunology Research

Volumn 2014, Issue , 2014, Pages

  Hanf, William ^a   Bonder, Claudine S ^b,c   Coates, P Toby H ^a,c  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b CENTRE FOR CANCER BIOLOGY   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C4D; HLA ANTIBODY; HLA ANTIBODY CLASS 1; HLA ANTIBODY CLASS 2; UNCLASSIFIED DRUG; AUTOANTIBODY; COMPLEMENT COMPONENT C4; HLA ANTIGEN;

ANTIBODY SPECIFICITY; CELL INTERACTION; DISEASE ASSOCIATION; DISEASE COURSE; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; GLOMERULOPATHY; HLA SYSTEM; HUMAN; INTRACELLULAR SIGNALING; KIDNEY TRANSPLANTATION; MOLECULAR INTERACTION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; TRANSPLANT GLOMERULOPATHY; ENDOTHELIUM; GLOMERULONEPHRITIS; IMMUNOLOGY; PATHOLOGY; TRANSPLANTATION;

ANTIBODY SPECIFICITY; AUTOANTIBODIES; COMPLEMENT C4; ENDOTHELIUM; GLOMERULONEPHRITIS; HLA ANTIGENS; HUMANS; PATIENT OUTCOME ASSESSMENT; RISK FACTORS; TRANSPLANTS;

EID: 84897510462     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2014/549315     Document Type: Review

References (82)

1. Naesens M., Kuypers D. R., de Vusser K., Vanrenterghem Y., Evenepoel P., Claes K., Bammens B., Meijers B., Lerut E., Chronic histological damage in early indication biopsies is an independent risk factor for late renal allograft failure. American Journal of Transplantation 2013 13 1 86 99
2. Cosio F. G., Gloor J. M., Sethi S., Stegall M. D., Transplant glomerulopathy. American Journal of Transplantation 2008 8 3 492 496 2-s2.0-39649115166 10.1111/j.1600-6143.2007.02104.x (Pubitemid 351287536)
3. John R., Konvalinka A., Tobar A., Kim S. J., Reich H. N., Herzenberg A. M., Determinants of long-term graft outcome in transplant glomerulopathy. Transplantation 2010 90 7 757 764 2-s2.0-77957974908 10.1097/TP.0b013e3181efcffd
4. Bentall A., Cornell L. D., Gloor J. M., Park W. D., Gandhi M. J., Winters J. L., Chedid M. F., Dean P. G., Stegall M. D., Five-year outcomes in living donor kidney transplants with a positive crossmatch. American Journal of Transplantation 2013 13 1 76 85
5. El-Zoghby Z. M., Stegall M. D., Lager D. J., Kremers W. K., Amer H., Gloor J. M., Cosio F. G., Identifying specific causes of kidney allograft loss. American Journal of Transplantation 2009 9 3 527 535 2-s2.0-60649101659 10.1111/j.1600-6143.2008.02519.x
6. Sun Q., Huang X., Jiang S., Picking transplant glomerulopathy out of the CAN: evidence from a clinico-pathological evaluation. BMC Nephrology 2012 13, article 128
7. Mengel M., Sis B., Haas M., Colvin R. B., Halloran P. F., Racusen L. C., Solez K., Cendales L., Demetris A. J., Drachenberg C. B., Farver C. F., Rodriguez E. R., Wallace W. D., Glotz D., Banff 2011 meeting report: new concepts in antibody-mediated rejection. American Journal of Transplantation 2012 12 3 563 570 2-s2.0-84857648352 10.1111/j.1600-6143.2011.03926.x
8. Wavamunno M. D., O'Connell P. J., Vitalone M., Fung C. L.-S., Allen R. D. M., Chapman J. R., Nankivell B. J., Transplant glomerulopathy: ultrastructural abnormalities occur early in longitudinal analysis of protocol biopsies. American Journal of Transplantation 2007 7 12 2757 2768 2-s2.0-35748959613 10.1111/j.1600-6143.2007.01995.x (Pubitemid 350045771)
9. Sijpkens Y. W., Joosten S. A., Wong M., Dekker F. W., Benediktsson H., Bajema I. M., Bruijn J. A., Paul L. C., Immunologic risk factors and glomerular C4d deposits in chronic transplant glomerulopathy. Kidney International 2004 65 6 2409 2418 2-s2.0-2442643785 10.1111/j.1523-1755.2004.00662.x (Pubitemid 38670027)
10. Suri D. L., Tomlanovich S. J., Olson J. L., Meyer T. W., Transplant glomerulopathy as a cause of late graft loss. American Journal of Kidney Diseases 2000 35 4 674 680 2-s2.0-0034069633 (Pubitemid 30185513)
11. Loupy A., Hil G. S., Noch D., Legendre C., Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. American Journal of Transplantation 2010 10 4 952 953 2-s2.0-77949836418 10.1111/j.1600-6143.2009.02974.x
12. Jordan S. C., Reinsmoen N., Lai C. H., Vo A., Novel immunotherapeutic approaches to improve rates and outcomes of transplantation in sensitized renal allograft recipients. Discovery Medicine 2012 13 70 235 245
13. Stegall M. D., Diwan T., Raghavaiah S., Cornell L. D., Burns J., Dean P. G., Cosio F. G., Gandhi M. J., Kremers W., Gloor J. M., Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients. American Journal of Transplantation 2011 11 11 2405 2413 2-s2.0-84555210096 10.1111/j.1600-6143.2011.03757.x
14. Hsu H. C., Suzuki Y., Churg J., Grishman E., Ultrastructure of transplant glomerulopathy. Histopathology 1980 4 4 351 367 2-s2.0-0018932983 (Pubitemid 10037070)
15. Haas M., Mirocha J., Early ultrastructural changes in renal allografts: correlation with antibody-mediated rejection and transplant glomerulopathy. American Journal of Transplantation 2011 11 10 2123 2131 2-s2.0-80053318052 10.1111/j.1600-6143.2011.03647.x
16. Maryniak R. K., First M. R., Weiss M. A., Transplant glomerulopathy: evolution of morphologically distinct changes. Kidney International 1985 27 5 799 806 2-s2.0-0021854866 (Pubitemid 15064642)
17. Cosio F. G., Grande J. P., Wadei H., Larson T. S., Griffin M. D., Stegall M. D., Predicting subsequent decline in kidney allograft function from early surveillance biopsies. American Journal of Transplantation 2005 5 10 2464 2472 2-s2.0-33644677802 10.1111/j.1600-6143.2005.01050.x
18. Baid-Agrawal S., Farris A. B., Pascual M., Mauiyyedi S., Farrell M. L., Tolkoff-Rubin N., Collins A. B., Frei U., Colvin R. B., Overlapping pathways to transplant glomerulopathy: chronic humoral rejection, hepatitis C infection, and thrombotic microangiopathy. Kidney International 2011 80 8 879 885 2-s2.0-80053505006 10.1038/ki.2011.194
19. Gloor J. M., Sethi S., Stegall M. D., Park W. D., Moore S. B., DeGoey S., Griffin M. D., Larson T. S., Cosio F. G., Transplant glomerulopathy: subclinical incidence and association with alloantibody. American Journal of Transplantation 2007 7 9 2124 2132 2-s2.0-34547850861 10.1111/j.1600-6143.2007. 01895.x (Pubitemid 47247042)
20. Wiebe C., Gibson I. W., Blydt-Hansen T. D., Karpinski M., Ho J., Storsley L. J., Goldberg A., Birk P. E., Rush D. N., Nickerson P. W., Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant. American Journal of Transplantation 2012 12 5 1157 1167 2-s2.0-84860473178 10.1111/j.1600-6143.2012.04013.x
21. Sellarés J., de Freitas D. G., Mengel M., Reeve J., Einecke G., Sis B., Hidalgo L. G., Famulski K., Matas A., Halloran P. F., Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. American Journal of Transplantation 2012 12 2 388 399 2-s2.0-84856411838 10.1111/j.1600-6143.2011.03840.x
22. Eng H. S., Bennett G., Chang S. H., Dent H., McDonald S. P., Bardy P., Coghlan P., Russ G. R., Coates P. T. H., Donor human leukocyte antigen specific antibodies predict development and define prognosis in transplant glomerulopathy. Human Immunology 2011 72 5 386 391 2-s2.0-79954596918 10.1016/j.humimm.2011.02.002
23. Habib R., Broyer M., Clinical significance of allograft glomerulopathy. Kidney International, Supplement 1993 43 S95 S98 2-s2.0-0003042950
24. Furness P. N., Taub N., International variation in the interpretation of renal transplant biopsies: report of the CERTPAP project. Kidney International 2001 60 5 1998 2012 2-s2.0-0034773612 10.1046/j.1523-1755.2001.00030.x (Pubitemid 33000007)
25. Lopez Jimenez V., Fuentes L., Jiménez T., Transplant glomerulopathy: clinical course and factors relating to graft survival. Transplantation Proceedings 2012 44 9 2599 2600
26. Sis B., Campbell P. M., Mueller T., Hunter C., Cockfield S. M., Cruz J., Meng C., Wishart D., Solez K., Halloran P. F., Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause. American Journal of Transplantation 2007 7 7 1743 1752 2-s2.0-34250215629 10.1111/j.1600-6143.2007.01836.x (Pubitemid 46905427)
27. Loupy A., Hill G. S., Suberbielle C., Charron D., Anglicheau D., Zuber J., Timsit M. O., Duong J. P., Bruneval P., Vernerey D., Empana J. P., Jouven X., Nochy D., Legendre C. H., Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA). American Journal of Transplantation 2011 11 1 56 65 2-s2.0-78650867494 10.1111/j.1600-6143.2010.03364.x
28. Patel A. M., Pancoska C., Mulgaonkar S., Weng F. L., Renal transplantation in patients with pre-transplant donor-specific antibodies and negative flow cytometry crossmatches. American Journal of Transplantation 2007 7 10 2371 2377 2-s2.0-34548361698 10.1111/j.1600-6143.2007.01944.x (Pubitemid 47347867)
29. Racusen L. C., Colvin R. B., Solez K., Mihatsch M. J., Halloran P. F., Campbell P. M., Cecka M. J., Cosyns J., Demetris A. J., Fishbein M. C., Fogo A., Furness P., Gibson I. W., Glotz D., Hayry P., Hunsickern L., Kashgarian M., Kerman R., Magil A. J., Montgomery R., Morozumi K., Nickeleit V., Randhawa P., Regele H., Seron D., Seshan S., Sund S., Trpkov K., Antibody-mediated rejection criteria-an addition to the Banff '97 classification of renal allograft rejection. American Journal of Transplantation 2003 3 6 708 714 2-s2.0-10744233377 10.1034/j.1600-6143.2003.00072.x (Pubitemid 36745243)
30. Solez K., Colvin R. B., Racusen L. C., Haas M., Sis B., Mengel M., Halloran P. F., Baldwin W., Banfi G., Collins A. B., Cosio F., David D. S. R., Drachenberg C., Einecke G., Fogo A. B., Gibson I. W., Glotz D., Iskandar S. S., Kraus E., Lerut E., Mannon R. B., Mihatsch M., Nankivell B. J., Nickeleit V., Papadimitriou J. C., Randhawa P., Regele H., Renaudin K., Roberts I., Seron D., Smith R. N., Valente M., Banff 07 classification of renal allograft pathology: updates and future directions. American Journal of Transplantation 2008 8 4 753 760 2-s2.0-40449101372 10.1111/j.1600-6143.2008.02159.x (Pubitemid 351347767)
31. Solez K., Colvin R. B., Racusen L. C., Sis B., Halloran P. F., Birk P. E., Campbell P. M., Cascalho M., Collins A. B., Demetris A. J., Drachenberg C. B., Gibson I. W., Grimm P. C., Haas M., Lerut E., Liapis H., Mannon R. B., Marcus P. B., Mengel M., Mihatsch M. J., Nankivell B. J., Nickeleit V., Papadimitriou J. C., Platt J. L., Randhawa P., Roberts I., Salinas-Madriga L., Salomon D. R., Seron D., Sheaff M., Weening J. J., Banff '05 meeting report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ("CAN"). American Journal of Transplantation 2007 7 3 518 526 2-s2.0-33847761900 10.1111/j.1600-6143.2006.01688.x (Pubitemid 46376465)
32. Lefaucheur C., Loupy A., Vernerey D., Antibody-mediated vascular rejection of kidney allografts: a population-based study. The Lancet 2013 381 9863 313 319
33. Einecke G., Mengel M., Hidalgo L., Allanach K., Famulski K. S., Halloran P. F., The early course of kidney allograft rejection: defining the time when rejection begins. American Journal of Transplantation 2009 9 3 483 493 2-s2.0-60649093376 10.1111/j.1600-6143.2008.02546.x
34. Mauiyyedi S., della Pelle P., Saidman S., Collins A. B., Pascual M., Tolkoff-Rubin N. E., Williams W. W., Cosimi A. B., Schneeberger E. E., Colvin R. B., Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. Journal of the American Society of Nephrology 2001 12 3 574 582 2-s2.0-0035122982 (Pubitemid 32180027)
35. Regele H., Böhmig G. A., Habicht A., Gollowitzer D., Schillinger M., Rockenschaub S., Watschinger B., Kerjaschki D., Exner M., Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection. Journal of the American Society of Nephrology 2002 13 9 2371 2380 2-s2.0-0036707891 10.1097/01.ASN.0000025780. 03790.0F (Pubitemid 34925248)
36. Batal I., Girnita A., Zeevi A., Saab B. A., Stockhausen S., Shapiro R., Basu A., Tan H., Morgan C., Randhawa P., Clinical significance of the distribution of C4d deposits in different anatomic compartments of the allograft kidney. Modern Pathology 2008 21 12 1490 1498 2-s2.0-56649114376 10.1038/modpathol.2008.152
37. Regele H., Exner M., Watschinger B., Wenter C., Wahrmann M., Österreicher C., Säemann M. D., Mersich N., Hörl W. H., Zlabinger G. J., Böhmig G. A., Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection. Nephrology Dialysis Transplantation 2001 16 10 2058 2066 2-s2.0-0034795579 (Pubitemid 32970570)
38. Tait B. D., Süsal C., Gebel H. M., Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation 2013 95 1 19 47
39. Cardarelli F., Pascual M., Tolkoff-Rubin N., Delmonico F. L., Wong W., Schoenfeld D. A., Zhang H., Benedict Cosimi A., Saidman S. L., Prevalence and significance of anti-HLA and donor-specific antibodies long-term after renal transplantation. Transplant International 2005 18 5 532 540 2-s2.0-23844479648 10.1111/j.1432-2277.2005.00085.x (Pubitemid 41726855)
40. Mizutani K., Terasaki P., Rosen A., Esquenazi V., Miller J., Shih R. N. J., Pei R., Ozawa M., Lee J., Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure. American Journal of Transplantation 2005 5 9 2265 2272 2-s2.0-25844453715 10.1111/j.1600-6143.2005.01016.x (Pubitemid 41648475)
41. Terasaki P. I., Ozawa M., Predicting kidney graft failure by HLA antibodies: a prospective trial. American Journal of Transplantation 2004 4 3 438 443 2-s2.0-1442314091 10.1111/j.1600-6143.2004.00360.x (Pubitemid 38282302)
42. Thaunat O., Hanf W., Dubois V., McGregor B., Perrat G., Chauvet C., Touraine J., Morelon E., Chronic humoral rejection mediated by anti-HLA-DP alloantibodies: insights into the role of epitope sharing in donor-specific and non-donor specific alloantibodies generation. Transplant Immunology 2009 20 4 209 211 2-s2.0-59749093983 10.1016/j.trim.2008.12.006
43. Worthington J. E., Martin S., Al-Husseini D. M., Dyer P. A., Johnson R. W. G., Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome. Transplantation 2003 75 7 1034 1040 2-s2.0-0037446624 (Pubitemid 36438534)
44. Musat A. I., Agni R. M., Wai P. Y., Pirsch J. D., Lorentzen D. F., Powell A., Leverson G. E., Bellingham J. M., Fernandez L. A., Foley D. P., Mezrich J. D., D'Alessandro A. M., Lucey M. R., The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. American Journal of Transplantation 2011 11 3 500 510 2-s2.0-79951976611 10.1111/j.1600-6143.2010.03414.x
45. Smith J. D., Banner N. R., Hamour I. M., Ozawa M., Goh A., Robinson D., Terasaki P. I., Rose M. L., De novo donor HLA-specific antibodies after heart transplantation are an independent predictor of poor patient survival. American Journal of Transplantation 2011 11 2 312 319 2-s2.0-79551472638 10.1111/j.1600-6143.2010.03383.x
46. Willicombe M., Brookes P., Sergeant R., De novo DQ donor-specific antibodies are associated with a significant risk of antibody-mediated rejection and transplant glomerulopathy. Transplantation 2012 94 2 172 177
47. Issa N., Cosio F. G., Gloor J. M., Sethi S., Dean P. G., Moore S. B., Degoey S., Stegall M. D., Transplant glomerulopathy: risk and prognosis related to anti-human leukocyte antigen class II antibody levels. Transplantation 2008 86 5 681 685 2-s2.0-53449101499 10.1097/TP.0b013e3181837626
48. Rostaing L., Guilbeau-Frugier C., Fort M., Mekhlati L., Kamar N., Treatment of symptomatic transplant glomerulopathy with rituximab. Transplant International 2009 22 9 906 913 2-s2.0-68849120899 10.1111/j.1432-2277.2009. 00896.x
49. Akalin E., Dinavahi R., Dikman S., de Boccardo G., Friedlander R., Schroppel B., Sehgal V., Bromberg J. S., Heeger P., Murphy B., Transplant glomerulopathy may occur in the absence of donor-specific antibody and C4d staining. Clinical Journal of the American Society of Nephrology 2007 2 6 1261 1267 2-s2.0-38449093287 10.2215/CJN.02420607
50. Nath D. S., Ilias Basha H., Tiriveedhi V., Alur C., Phelan D., Ewald G. A., Moazami N., Mohanakumar T., Characterization of immune responses to cardiac self-antigens myosin and vimentin in human cardiac allograft recipients with antibody-mediated rejection and cardiac allograft vasculopathy. Journal of Heart and Lung Transplantation 2010 29 11 1277 1285 2-s2.0-78049300076 10.1016/j.healun.2010.05.025
51. Dragun D., Müller D. N., Bräsen J. H., Fritsche L., Nieminen-Kelhä M., Dechend R., Kintscher U., Rudolph B., Hoebeke J., Eckert D., Mazak I., Plehm R., Schönemann C., Unger T., Budde K., Neumayer H., Luft F. C., Wallukat G., Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. The New England Journal of Medicine 2005 352 6 558 569 2-s2.0-13444267698 10.1056/NEJMoa035717 (Pubitemid 40204669)
52. Sutherland S. M., Li L., Sigdel T. K., Wadia P. P., Miklos D. B., Butte A. J., Sarwal M. M., Protein microarrays identify antibodies to protein kinase C that are associated with a greater risk of allograft loss in pediatric renal transplant recipients. Kidney International 2009 76 12 1277 1283 2-s2.0-71149110127 10.1038/ki.2009.384
53. Dinavahi R., George A., Tretin A., Akalin E., Ames S., Bromberg J. S., DeBoccardo G., DiPaola N., Lerner S. M., Mehrotra A., Murphy B. T., Nadasdy T., Paz-Artal E., Salomon D. R., Schröppel B., Sehgal V., Sachidanandam R., Heeger P. S., Antibodies reactive to Non-HLA antigens in transplant glomerulopathy. Journal of the American Society of Nephrology 2011 22 6 1168 1178 2-s2.0-79957784155 10.1681/ASN.2010111183
54. Sigdel T. K., Li L., Tran T. Q., Khatri P., Naesens M., Sansanwal P., Dai H., Hsieh S., Sarwal M. M., Non-HLA antibodies to immunogenic epitopes predict the evolution of chronic renal allograft injury. Journal of the American Society of Nephrology 2012 23 4 750 763 2-s2.0-84859858471 10.1681/ASN.2011060596
55. Colvin R. B., Antibody-mediated renal allograft rejection: diagnosis and pathogenesis. Journal of the American Society of Nephrology 2007 18 4 1046 1056 2-s2.0-34047236016 10.1681/ASN.2007010073 (Pubitemid 46536891)
56. Bartel G., Wahrmann M., Exner M., Regele H., Schillinger M., Hörl W. H., Böhmig G. A., Determinants of the complement-fixing ability of recipient presensitization against HLA antigens. Transplantation 2007 83 6 727 733 2-s2.0-34147181150 10.1097/01.tp.0000256337.18347.aa (Pubitemid 46569190)
57. Sis B., Jhangri G. S., Bunnag S., Allanach K., Kaplan B., Halloran P. F., Endothelial gene expression in kidney transplants with alloantibody indicates Antibody-mediated damage despite lack of C4d staining. American Journal of Transplantation 2009 9 10 2312 2323 2-s2.0-70349196778 10.1111/j.1600-6143.2009. 02761.x
58. Sis B., Jhangri G. S., Riopel J., Chang J., de Freitas D. G., Hidalgo L., Mengel M., Matas A., Halloran P. F., A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants. American Journal of Transplantation 2012 12 5 1168 1179 2-s2.0-84860452194 10.1111/j.1600-6143.2011.03931.x
59. Sis B., Endothelial molecules decipher the mechanisms and functional pathways in antibody-mediated rejection. Human Immunology 2012 73 12 1218 1225
60. Jindra P. T., Jin Y., Rozengurt E., Reed E. F., HLA class I antibody-mediated endothelial cell proliferation via the mTOR pathway. Journal of Immunology 2008 180 4 2357 2366 2-s2.0-40849138320
61. Jindra P. T., Hsueh A., Hong L., Gjertson D., Shen X., Gao F., Dang J., Mischel P. S., Baldwin W. M. III, Fishbein M. C., Kupiec-Weglinski J. W., Reed E. F., Anti-MHC class I antibody activation of proliferation and survival signaling in murine cardiac allografts. Journal of Immunology 2008 180 4 2214 2224 2-s2.0-40849127258
62. Iwasaki K., Miwa Y., Ogawa H., Yazaki S., Iwamoto M., Furusawa T., Onishi A., Kuzuya T., Haneda M., Watarai Y., Uchida K., Kobayashi T., Comparative study on signal transduction in endothelial cells after anti-A/B and human leukocyte antigen antibody reaction: implication of accommodation. Transplantation 2012 93 4 390 397 2-s2.0-84857062399 10.1097/TP.0b013e3182424df3
63. Zhang X., Reed E. F., HLA class I: an unexpected role in integrin beta4 signaling in endothelial cells. Human Immunology 2012 73 12 1239 1244
64. Ziegler M. E., Souda P., Jin Y., Whitelegge J. P., Reed E. F., Characterization of the endothelial cell cytoskeleton following HLA class I ligation. PLoS ONE 2012 7 1 2-s2.0-84855667079 10.1371/journal.pone.0029472 e29472
65. 2+ in human aortic endothelial cells. American Journal of Physiology-Cell Physiology 2012 303 8 C872 C882
66. Valenzuela N. M., Hong L., Shen X. D., Gao F., Young S. H., Rozengurt E., Kupiec-Weglinski J. W., Fishbein M. C., Reed E. F., Blockade of p-selectin is sufficient to reduce MHC I antibody-elicited monocyte recruitment in vitro and in vivo. American Journal of Transplantation 2013 13 2 299 311
67. Lepin E. J., Zhang Q., Zhang X., Jindra P. T., Hong L. S., Ayele P., Peralta M. V. P., Gjertson D. W., Kobashigawa J. A., Wallace W. D., Fishbein M. C., Reed E. F., Phosphorylated S6 ribosomal protein: a novel biomarker of antibody-mediated rejection in heart allografts. American Journal of Transplantation 2006 6 7 1560 1571 2-s2.0-33745439024 10.1111/j.1600-6143.2006. 01355.x (Pubitemid 43948221)
68. Haraldsson B., Nyström J., The glomerular endothelium: new insights on function and structure. Current Opinion in Nephrology and Hypertension 2012 21 3 258 263 2-s2.0-84859628352 10.1097/MNH.0b013e3283522e7a
69. Satchell S. C., Braet F., Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier. American Journal of Physiology-Renal Physiology 2009 296 5 F947 F956 2-s2.0-66049109286 10.1152/ajprenal.90601.2008
70. Hamer R., Molostvov G., Lowe D., Satchell S., Mathieson P., Ilyas R., Mitchell D. A., Lam F. T., Kashi H., Tan L. C., Imray C., Fletcher S., Briggs D., Krishnan N., Higgins R., Zehnder D., Human leukocyte antigen-specific antibodies and gamma-interferon stimulate human microvascular and glomerular endothelial cells to produce complement factor C4. Transplantation 2012 93 9 867 873 2-s2.0-84857315814 10.1097/TP.0b013e31824b3762
71. Smith R. N., Kawai T., Boskovic S., Nadazdin O., Sachs D. H., Cosimi A. B., Colvin R. B., Four stages and lack of stable accommodation in chronic alloantibody-mediated renal allograft rejection in cynomolgus monkeys. American Journal of Transplantation 2008 8 8 1662 1672 2-s2.0-48349092133 10.1111/j.1600-6143.2008.02303.x
72. Bakris G. L., Slowing nephropathy progression: focus on proteinuria reduction. Clinical Journal of the American Society of Nephrology 2008 3 supplement 1 S3 S10 2-s2.0-40149083478 10.2215/CJN.03250807
73. Gloor J., Stegall M. D., Sensitized renal transplant recipients: current protocols and future directions. Nature Reviews Nephrology 2010 6 5 297 306 2-s2.0-77951879759 10.1038/nrneph.2010.34
74. Kohei N., Hirai T., Omoto K., Ishida H., Tanabe K., Chronic antibody-mediated rejection is reduced by targeting B-cell immunity during an introductory period. American Journal of Transplantation 2012 12 2 469 476 2-s2.0-84856436154 10.1111/j.1600-6143.2011.03830.x
75. Lefaucheur C., Nochy D., Andrade J., Verine J., Gautreau C., Charron D., Hill G. S., Glotz D., Suberbielle-Boissel C., Comparison of combination plasmapheresis/IVIg/Anti-CD20 versus high-dose ivig in the treatment of antibody-mediated rejection. American Journal of Transplantation 2009 9 5 1099 1107 2-s2.0-65249111644 10.1111/j.1600-6143.2009.02591.x
76. Gomez A. M., Vrolix K., Martínez-Martínez P., Molenaar P. C., Phernambucq M., Van Der Esch E., Duimel H., Verheyen F., Voll R. E., Manz R. A., de Baets M. H., Losen M., Proteasome inhibition with bortezomib depletes plasma cells and autoantibodies in experimental autoimmune myasthenia gravis. Journal of Immunology 2011 186 4 2503 2513 2-s2.0-79951838009 10.4049/jimmunol.1002539
77. Vogelbacher R., Meister S., Gückel E., Starke C., Wittmann S., Stief A., Voll R., Daniel C., Hugo C., Bortezomib and sirolimus inhibit the chronic active antibody-mediated rejection in experimental renal transplantation in the rat. Nephrology, Dialysis, Transplantation 2010 25 11 3764 3773 2-s2.0-79952198748
78. Schwaiger E., Regele H., Wahrmann M., Werzowa J., Haidbauer B., Schmidt A., Böhmig G. A., Bortezomib for the treatment of chronic antibody-mediated kidney allograft rejection: a case report. Clinical Transplants 2010 391 396 2-s2.0-79960074244
79. Nigos J. G., Arora S., Nath P., Hussain S. M., Marcus R. J., Ko T. Y., Sureshkumar K. K., Treatment of antibody-mediated rejection in kidney transplant recipients: a single-center experience with a bortezomib-based regimen. Experimental and Clinical Transplantation 2012 10 6 609 613
80. Hillmen P., Young N. S., Schubert J., Brodsky R. A., Socié G., Muus P., Röth A., Szer J., Elebute M. O., Nakamura R., Browne P., Risitano A. M., Hill A., Schrezenmeier H., Fu C., Maciejewski J., Rollins S. A., Mojcik C. F., Rother R. P., Luzzatto L., The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. The New England Journal of Medicine 2006 355 12 1233 1243 2-s2.0-33748904355 10.1056/NEJMoa061648 (Pubitemid 44427447)
81. Stegall M. D., Chedid M. F., Cornell L. D., The role of complement in antibody-mediated rejection in kidney transplantation. Nature Reviews Nephrology 2012 8 11 670 678
82. Cornell L. D., Chronic antibody mediated histological changes in positive-crossmatch kidney transplants (+XMKTx) receiving early C5 blockade. LB26, ATC. Journal of Transplantation 2012 supplement 3 450